In summary, the current study shows that in vivo molecular imaging of intra-tumoural granzyme B using [18F]AlF-mNOTA-GZP is able to stratify tumour response to a range of ICIs administered to preclinical colon cancer models given as monotherapies or in combination. The gene discussed is GZMB; the disease is malignant colon neoplasm.